4//SEC Filing
BALEZENTIS CARL W 4
Accession 0001179110-04-009133
CIK 0001110009other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 12:18 PM ET
Size
17.8 KB
Accession
0001179110-04-009133
Insider Transaction Report
Form 4
BALEZENTIS CARL W
Sr. V.P & President, Lark
Transactions
- Award
Stock Option (right to buy)
2004-04-01+63,350→ 63,350 totalExercise: $0.66From: 2005-09-05Exp: 2011-09-05→ Common Stock (63,350 underlying) - Award
Stock Option (right to buy)
2004-04-01+108,600→ 108,600 totalExercise: $0.66From: 2006-01-01Exp: 2012-01-01→ Common Stock (108,600 underlying) - Award
Stock option (right to buy)
2004-04-01$3.49/sh+100,000$349,000→ 100,000 totalExercise: $3.49From: 2008-04-01Exp: 2014-04-01→ Common Stock (100,000 underlying) - Award
Stock Option (right to buy)
2004-04-01+31,675→ 31,675 totalExercise: $0.66From: 2004-10-30Exp: 2010-10-30→ Common Stock (31,675 underlying) - Award
Stock Option (right to buy)
2004-04-01+58,186→ 58,186 totalExercise: $0.88From: 2007-03-03Exp: 2013-03-03→ Common Stock (58,186 underlying)
Footnotes (6)
- [F1]This option vests quarterly over 4 years.
- [F2]Dr. Balezentis received this option in the merger among the issuer, Brown Acquisition Corp and Lark Technologies, Inc. (the "Merger") in exchange for an option to purchase 17,500 shares of Lark Technologies common stock for $1.19 per share. This stock option provides for vesting of 25% of the original number of shares on the anniversary of the option grant over a four year period with the final vesting on October 30, 2004.
- [F3]Dr. Balezentis received this option in the Merger in exchange for an option to purchase 17,500 shares of Lark Technologies common stock for $1.19 per share. This stock option provides for vesting of 25% of the original number of shares on the anniversary of the option grant over a four year period with the final vesting on July 31, 2005.
- [F4]Dr. Balezentis received this option in the Merger in exchange for an option to purchase 35,000 shares of Lark Technologies common stock for $1.19 per share. This stock option provides for vesting of 25% of the original number of shares on the anniversary of the option grant over a four year period with the final vesting on September 5, 2005.
- [F5]Dr. Balezentis received this option in the Merger in exchange for an option to purchase 60,000 shares of Lark Technologies common stock for $1.19 per share. This stock option provides for vesting of 25% of the original number of shares on the anniversary of the option grant over a four year period with the final vesting on January 1, 2006.
- [F6]Dr. Balezentis received this option in the Merger in exchange for an option to purchase 32,147 shares of Lark Technologies common stock for $1.59 per share. This stock option provides for vesting of 25% of the original number of shares on the anniversary of the option grant over a four year period with the final vesting on March 3, 2007.
Documents
Issuer
GENAISSANCE PHARMACEUTICALS INC
CIK 0001110009
Entity typeother
Related Parties
1- filerCIK 0001286811
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 12:18 PM ET
- Size
- 17.8 KB